INOVIO PHARMACEUTICALS INC(NASDAQ:INO) stock News

INO Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Inovio Pharmaceuticals, Inc.

INOVIO Reports Inducement Grant Under Inducement Plan

13 days ago - By: Inovio Pharmaceuticals, Inc.

INOVIO to Participate in Upcoming Scientific Conferences

a month ago - By: Zacks Investment Research - Mentions: CRMD KNSA PGEN

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

a month ago - By: Inovio Pharmaceuticals, Inc.

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

a month ago - By: Inovio Pharmaceuticals, Inc.

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

2 months ago - By: Benzinga

Earnings Outlook For Inovio Pharmaceuticals

3 months ago - By: Benzinga - Mentions: OLO FC TRIP NCPL ...

Crude Oil Down 1%; Tripadvisor Shares Jump

3 months ago - By: Inovio Pharmaceuticals, Inc.

INOVIO Announces Pricing of $25 Million Public Offering

2 months ago - By: The Motley Fool

Inovio Cuts Q2 Losses by 27%

2 months ago - By: Inovio Pharmaceuticals, Inc.

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

3 months ago - By: Inovio Pharmaceuticals, Inc.

INOVIO Announces Proposed Public Offering

2 months ago - By: Zacks Investment Research - Mentions: AGEN

Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates

2 months ago - By: Zacks Investment Research - Mentions: GILD DERM ZVRA

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

2 months ago - By: Inovio Pharmaceuticals, Inc.

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

2 months ago - By: Zacks Investment Research - Mentions: DNTH

Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline

2 months ago - By: Zacks Investment Research - Mentions: VTGN

Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?

2 months ago - By: Inovio Pharmaceuticals, Inc.

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

3 months ago - By: AVACTA GROUP PLC - Mentions: LSE -

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

5 months ago - By: Zacks Investment Research - Mentions: FHTX

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

5 months ago - By: Inovio Pharmaceuticals, Inc.

INOVIO PHARMACEUTICALS INC (INO) Stock News

INO Latest News, Press Relases and Analysis

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO to Participate in Upcoming Scientific Conferences

INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug

INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults

INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Earnings Outlook For Inovio Pharmaceuticals

Crude Oil Down 1%; Tripadvisor Shares Jump

INOVIO Announces Pricing of $25 Million Public Offering

Inovio Cuts Q2 Losses by 27%

INOVIO Reports Second Quarter 2025 Financial Results and Recent Business Highlights

INOVIO Announces Proposed Public Offering

Agenus (AGEN) Reports Q2 Loss, Beats Revenue Estimates

3 Biotech Stocks Likely to Outpace Q2 Earnings Estimates

Data Published in The Laryngoscope shows INO-3107 Resulted in Long-Term Surgery Reduction in Recurrent Respiratory Papillomatosis (RRP)

Earnings Preview: Dianthus Therapeutics, Inc. (DNTH) Q2 Earnings Expected to Decline

Inovio Pharmaceuticals (INO) Expected to Beat Earnings Estimates: Should You Buy?

INOVIO to Report Second Quarter 2025 Financial Results on August 12, 2025

Avacta Appoints David Liebowitz, M.D., Ph.D. as Chief Medical Officer and Yulii Bogatyrenko as Advisor in Business Development

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights